A functional comparison was made between the wildtype bradykinin B 2 receptor (B 2 wt) and the chimera B 2 eGFP (enhanced green-fluorescent protein fused to the C-terminus of B 2 wt), both stably expressed in HEK 293 cells. There was almost no difference in terms of ligandinducible receptor phosphorylation and internalization, signal transduction (accumulation of inositol phosphates) or expression and affinity. However, stimulation for up to 8 h with 10 mM bradykinin (BK) resulted in a strong decrease in surface receptors (by 60% within 5 h) in B 2 wt, but not in B 2 eGFP. When the expression levels of both constructs where comparably reduced using a weaker promoter, long-term stimulation resulted in a reduction in surface receptors for B 2 wt low to less than 20% within 1 h, whereas the chimera B 2 eGFP low still displayed 50% binding activity after 2 h. A 1-h incubation in the absence of BK resulted in a recovery of 60% of the binding in B 2 wt low after 1-h stimulation with BK, but of only 20% after 7-h stimulation. In contrast, B 2 eGFP low levels were restored to more than 70%, even after 7-h stimulation. These data indicate that although the fusion of eGFP to B 2 wt does not affect its ligand-induced internalization, it strongly reduces the down-regulation, most likely by promoting receptor recycling over degradation.
Introduction
G protein-coupled receptors (GPCRs) form the largest membrane-receptor group in the mammalian genome (Fredriksson et al., 2003) . More than 40% of all commercially available drugs exert their effects via members of this group. Therefore, strong efforts have been made in academia and in pharmaceutical industry research to elucidate the mechanisms that regulate the functions of these receptors, in particular the processes that are involved in the activation or de-and resensitization of the receptors (Pierce et al., 2002; Brink et al., 2004; Maxfield and McGraw, 2004) .
Our group focuses on the regulation and signaling of the bradykinin B 2 receptor (B 2 wt). This receptor belongs to family A of the GPCRs (Hess et al., 1992) , i.e., the rhodopsin/b-adrenergic-like receptors, and transmits signaling of the small extracellular peptides bradykinin and kallidin (Leeb-Lundberg et al., 2005) to intracellular compartments. The effects of these hormones include pain sensation, vascular permeability resulting in edema, and vasodilatation (Proud, 1988; Regoli et al., 2001; Stewart, 2004) .
After stimulation with an agonist, most GPCRs sequester to intracellular compartments. One elegant tool widely applied to investigate the localization and trafficking of receptor proteins in a living cell is the expression of the receptors as fusion proteins with green-fluorescent protein (GFP) or derivatives thereof (Kallal et al., 1998; Milligan, 1999; Houle and Marceau, 2003) . Although widely used, not many data are available that describe in detail whether and how joining GFP to the C-terminus of a GPCR influences its overall behavior.
Therefore, we set out to determine whether fusion to enhanced GFP (eGFP) changes the characteristics of the bradykinin B 2 receptor with respect to receptor trafficking, affinity shift and signal transduction. Moreover, experimental conditions such as receptor expression levels and short-or long-term stimulation where also investigated in detail. Taken together, the results indicate that fusion of eGFP to the C-terminus of the bradykinin B 2 receptor does not affect its ligand-induced internalization, but strongly reduces receptor down-regulation, most likely via enhancement of receptor recycling.
Results
To determine to what extent ligation of eGFP to B 2 wt affects its characteristics, we investigated several parameters: ligand affinity at 48C and 378C, accumulation of inositol phosphates (IPs), basal and ligand-inducible phosphorylation and internalization, and receptor downregulation. As the eGFP was fused to the C-terminus of B 2 wt, this C-terminus was the main candidate domain for which function could be affected. Therefore, we also compared both constructs (B 2 wt and B 2 eGFP) with the B 2 receptor truncation K315stop as a control. This mutant is lacking the last 50 amino acids of the C-terminus due to insertion of a stop codon after lysine 315 and can serve as an example for the characteristics of a mutant with an extremely truncated C-terminus.
Fusion with eGFP does not affect receptor expression or affinity
Tagging the C-terminus of the B 2 wt receptor with eGFP apparently did not affect receptor expression, as B 2 wt and B 2 eGFP with approximately 10 pmol/mg protein were both similarly overexpressed (Table 1) . The Flp-In expression system uses the transient co-expression of a recombinase to insert the gene of interest at a specific site in the genome of a host cell line. Thus, the distinctly lower expression level of truncation K315stop most likely reflects differences in posttranscriptional or posttranslational processes, such as trafficking and/or protein turnover, caused by the lack of the C-terminus that were obviously not mimicked by the fusion of eGFP to the receptor C-terminus.
When sequestration of B 2 wt is inhibited by preincubation of the cells with phenylarsine oxide, it is possible to determine the equilibrium binding constant (K d ) at 48C, as well as at 378C . B 2 wt showed a shift to lower affinity when the temperature was increased from 48C to 378C and vice versa. In contrast, the mutant receptor K315stop did not exhibit significantly lower affinity at 378C than at 48C, indicating that the Cterminally truncated receptor is trapped in a conformation with higher affinity. However, it is not yet clear whether this is an intrinsic property of the truncation mutant or due to interactions with other intracellular proteins that have been changed by the lack of the C-terminus. The B 2 eGFP chimera, however, still displayed shift behavior similar to the B 2 wt ( Table 1 ), suggesting that tagging with eGFP does not hamper the role that the Cterminus plays in the affinity shift.
B 2 eGFP mediates release of total inositol phosphate levels comparable to B 2 wt When challenged with bradykinin (BK), B 2 wt and B 2 eGFP induced an accumulation of total inositol phosphates that was almost identical in terms of potency (EC 50 ) and efficacy (maximal effect). In contrast, the K315stop receptor mutant exhibited a reduced maximal effect -probably due to its lower expression level -and a more than 10-fold shift of the EC 50 to lower values ( Table 1 ), indicating that the C-terminus directly or indirectly plays a role in the coupling of the receptor to G protein G q/11 . Again this function was not affected by C-terminal fusion of the receptor to eGFP.
B 2 wt and B 2 eGFP display equally fast internalization
As we have shown recently using high ligand concentrations, the rate of w 3 HxBK uptake (ligand internalization) decreases in cells overexpressing B 2 wt when too many receptors are occupied (Faussner et al., 2003) . Therefore, we took care to apply a w 3 HxBK concentration below the K d value, at which the internalization rate is largely concentration-independent, even for high expression levels.
At these low concentrations, the decrease in surface binding and the increase in internalized w 3 HxBK for the chimeric construct B 2 eGFP were similar to the rates observed for B 2 wt ( Figure 1A , B). For both constructs, more than 80% of total bound w 3 HxBK could be detected inside the cells within 10 min ( Figure 1C ), indicating that joining of the 27-kDa eGFP protein to the C-terminus of B 2 wt does not affect the interaction of this domain with the internalization machinery of the cell. Mutant receptor K315stop, however, exhibited very little internalization, not surpassing 20% after 30 min, thus confirming our results obtained in Chinese hamster ovary cells (Faussner et al., 1998) and the general importance of this receptor part for receptor internalization.
Phosphorylation patterns of B 2 wt and B 2 eGFP reflect their agonist-inducible internalization B 2 wt displayed distinct phosphorylation, even in the absence of a stimulus (Figure 2 ), as previously reported for HEK 293 cells and human fibroblasts (Blaukat et al., 2001; Kalatskaya et al., 2004) . When stimulated for 5 min with a saturating concentration of 1 mM BK at 378C, B 2 wt responded with a marked increase (2.5"0.06-fold over basal, ns3) in phosphorylation. Interestingly, B 2 eGFP exhibited even stronger basal phosphorylation, with bands appearing in the region of 80-110 kDa, as could be expected for the larger chimera ( Figure 2 ). Nevertheless, the fusion protein still responded to BK stimulation with a significant increase in phosphorylation (1.3"0.03-fold over basal, ns3). Mutant K315stop lost all phosphorylation sites, and therefore no basal or stimulated phosphorylation could be expected (Blaukat et al., 2001 ).
Stability of BK in cell culture medium
To study B 2 wt down-regulation, it is necessary to stimulate the receptor over a period of several hours with an agonist. Bradykinin, however, is a very good substrate, especially for metalloproteases (Dendorfer et al., 1997; Stewart, 2004) found either on the cell membrane such as neutral endopeptidase (NEP, neprilysin) or in serum added to the cell culture medium (Bachvarov et al., 2001 ). The addition of protease inhibitors, such as 1,10-phenanthroline, to prevent proteolysis of the labeled or unlabeled BK is tolerated by cells for only short incubation times for the binding or stimulation periods (Faussner et al., 2003 . However, the cells do not tolerate such additives for the longer periods necessary for down-regulation experiments. To avoid long-term exposure to these harmful protease inhibitors, we tested the stability of BK at 378C in a cell culture medium supplemented with fetal calf serum (10% v/v) for which the proteolytic activity was strongly reduced by incubation for 2 h at 608C. To determine the effectiveness of this pretreatment, intact BK (initially 10 mM) in the supplemented medium was tested after various times for binding to the receptor in a competition assay with w 
Highly expressed B 2 eGFP displays no downregulation
When monolayers of B 2 wt-expressing HEK 293 cells were incubated in cell culture medium supplemented with inactivated fetal calf serum for up to 24 h with 10 mM BK, a clear decrease in surface binding could be observed for B 2 wt, which after 5 h reached a plateau of -40% of the control binding measured in unstimulated cells (Figure 4 ). The rate of decrease strongly depended on the expression level, as indicated by another HEK 293 clone (B 2 wt low ) expressing the same B 2 wt construct under the control of the weaker promoter P min . The use of this weaker promoter resulted in distinctly lower expression, with 4.4 compared to 10.4 pmol/ mg protein of B 2 wt expression obtained under the control of the standard CMV promoter (Table 1) . The constructtermed B 2 wt low -responds to prolonged BK stimulation with a reduction in surface binding of 90% within 2 h (Figure 4) , thus stressing the influence of the receptor expression level on the outcome of a down-regulation experiment.
When challenged with BK, the chimera B 2 eGFP showed no loss of surface binding at all, even after 8 h of stimulation with an initial concentration of 10 mM BK (Figure 4 ). Only after longer incubation periods for up to 24 h could a decrease in binding be measured (data not shown). As almost all cells expressing bradykinin B 2 receptors and variants thereof responded to prolonged exposure to BK with strong cell contraction and weakened adherence to the cell culture plate, it is not clear whether this apparent decrease in agonist binding should be considered as receptor down-regulation or rather as the result of general degeneration of the cells caused by overstimulation.
To test whether the apparent lack of B 2 eGFP downregulation during an 8-h incubation time is absolute or in part due to the strong receptor overexpression, we also generated clones expressing the chimera B 2 eGFP at a distinctly lower level (4 pmol/mg protein) under the control of the promoter P min (termed B 2 eGFP low ). In this case, stimulation with BK resulted in reduced surface binding resembling that of the highly expressed B 2 wt ( Figure 4) ; thus, it was much less pronounced than the reduction observed for B 2 wt low expressed at a comparable level. These data indicate that fusion of eGFP to the C-terminus of the bradykinin B 2 receptor strongly reduces but does not completely block its down-regulation.
Despite its low receptor expression, the truncation mutant K315stop showed no decrease at all in agonist binding even after 8 h of stimulation with BK, suggesting that ligand-induced receptor down-regulation requires either internalization of the receptor or at least (modification of) specific sequences in the C-terminal receptor domain as a first step.
Fusion to eGFP results in enhanced recycling of the B 2 receptor
The fast internalization of w 3 HxBK, but no (B 2 eGFP) or only a slow decrease (B 2 eGFP low ) in the cell surface-receptor number after stimulation suggests that there is significant recycling of the B 2 eGFP chimera after internalization. In addition, it is of interest to know whether the reduced receptor number on the cell surface after long-term stimulation constitutes true down-regulation, i.e., inactivation/ degradation of the sequestered receptors, or whether they can reappear at the cell surface to a lesser degree after removal of the stimulus. Roscher et al. (1984) showed that after short stimulation of 15 min with a saturating concentration of BK, a recovery time of 1 h is enough to restore binding almost completely in human fibroblasts. As this recovery was culture medium containing 10% inactivated fetal calf serum (FCS). The remaining surface binding was either determined immediately (n,s) as described in the legend to Figure 4 or the monolayers were washed and further incubated for 1 h at 378C in medium with fresh FCS to promote degradation of residual BK and allow receptor recycling back to the cell membrane, before the remaining surface binding was determined as described above (m, d). Symbols represent the mean"SD for three experiments performed in duplicate.
unaffected by cycloheximide, it necessarily implied recycling of the receptors. We tested, therefore, the capability of the low-expressing cells to recover receptor binding after incubation for 1 h in the absence of BK.
Stimulation of B 2 wt low with a saturating concentration of 10 mM BK resulted in a fast decrease in surface binding ( Figure 5A ; see also Figure 4 ). Although stimulation for 1 h produced a decrease to -20% of the initial binding, subsequent incubation at 378C in the absence of BK generated a recovery in binding to almost 60%, indicating that a greater proportion of the sequestered receptors was not degraded after 1 h, but could be recycled back to the cell surface. Stimulation with BK for more than 1 h strongly diminished this capability to recover, implying that degradation had overtaken recycling ( Figure 5A ). For the chimera B 2 eGFP low the situation was clearly different. The reduction in cell surface receptor number caused by stimulation with BK for up to 2 h (approx. 50%) could be nearly completely restored by incubation for 1 h in the absence of BK ( Figure 5B ), and even after a stimulation period of 7 h almost 70% of the receptors reappeared after 1 h without stimulus, suggesting that even during prolonged stimulation most of the chimera continues to recycle between the cell surface and intracellular compartments. This clearly indicates that the fusion of eGFP to the receptor C-terminus strongly promotes recycling of the receptor, thus overcoming its degradation. It also explains the apparently poor sequestration, i.e., the reduction in receptor number on the cell surface after stimulation, unequivocally observed for the chimera (Figure 4) .
Discussion
Many GPCRs respond to stimulation by an agonist with sequestration of the receptor from the cell surface to intracellular compartments such as early endosomes. From there, they either return to the cell surface (recycling) or end up in lysosomes and are degraded (down-regulation). As this receptor endocytosis and its regulation play a pivotal role in the control of cell responsiveness to extracellular stimuli, elucidation of the mechanisms involved is a main focus of ongoing research in the GPCR field (Ferguson, 2001; Marchese et al., 2003) . One widely used tool is the generation of receptor chimeras with eGFP that allow the direct tracking of a receptor within a living cell with the help of fluorescence microscopy. For GPCRs, the fluorescent protein has been exclusively joined to the intracellular C-terminus. The current model of receptor internalization -resulting predominantly from data obtained for the b 2 -adrenergic receptor (Perry and Lefkowitz, 2002 ) -starts with the phosphorylation of specific Ser/Thr-residues in the C-terminus through the action of second-messenger activated kinases and/or the more receptor-specific GRKs (G protein-coupled receptor kinases). Subsequently, adaptor proteins such as arrestins bind to these phosphorylated sequences and mediate the translocation of the receptor to and its internalization through clathrin-coated pits (Mousavi et al., 2004) or other less well-understood mechanisms, such as pathways involving caveolae (Haasemann et al., 1998; Roseberry and Hosey, 2001) .
The almost complete absence of receptor internalization observed in the B 2 truncation mutant K315stop (Faussner et al., 1998;  Figure 1C ) demonstrates the relevance of the intact C-terminus for this function in B 2 wt. It has also been shown for B 2 wt that the phosphorylation of Ser/Thr residues is indispensable for fast sequestration (Blaukat et al., 2001) . Deglycosylated B 2 wt has a molecular mass of approximately 40 kDa and its C-terminus consists of only approximately 60 amino acid residues. For this reason it cannot be taken for granted that tagging the C-terminus with a 27-kDa protein would not interfere with its function, in particular with the receptor trafficking that largely depends on this domain.
On first sight, B 2 eGFP displayed properties similar to those of B 2 wt: it bound w 3 HxBK with the same affinity and had a similar expression level. In addition, B 2 eGFP was located almost exclusively at the membrane and was found in intracellular vesicles of various sizes only after stimulation with BK (data not shown here, but reported by Kalatskaya et al., 2004) , in full agreement with other reports (Bachvarov et al., 2001; Sabourin et al., 2002; Simaan et al., 2005) . The fusion protein can interact normally with its cognate G proteins, as it exhibited a low level of basal signaling and IP accumulation could be stimulated several-fold above this basal level. Moreover, similar to B 2 wt, B 2 eGFP displayed a clear temperaturedependent affinity shift, indicating proper interaction at the plasma membrane with the cognate G protein and/ or other cytosolic proteins (Mitchell et al., 1998; Gether, 2000) . Finally, the chimera B 2 eGFP displayed significant ligand-inducible phosphorylation and fast ligand internalization comparable to that of B 2 wt. The properties of the truncation receptor K315stop demonstrated that the C-terminus plays an important role in all these processes, as this mutant lacking the C-terminus displayed no affinity shift, whereas its signaling exhibited a more than 10-fold shift of EC 50 to lower values for IP accumulation (Table 1) . This lower EC 50 may also explain the apparently strong reduction in maximal effect (by 70%) found for similar truncation of the rat bradykinin B 2 receptor, as a low concentration of 10 nM BK was used to determine the maximal effect (Prado et al., 1997) .
The truncation mutant K315stop showed no decrease in surface binding, even after prolonged stimulation with BK, suggesting that ligand-induced receptor down-regulation requires either internalization of the receptor or specific sequences and/or modification thereof in the Cterminal receptor domain as a first step. This, and the fact that internalization but not down-regulation remained unchanged in the presence of eGFP, indicates that these two processes are sequential and that they can be uncoupled by fusion of the receptor to eGFP. Thus, these data are in contrast to results obtained for the angiotensin AT 1 receptor, for which down-regulation was reported to be independent of ligand-inducible receptor endocytosis (Modrall et al., 2001) . Two AT 1 truncation mutants, comparable to K315stop, did not internalize, but could nevertheless be down-regulated to 60% within 8 h, similar to the wild type AT 1 receptor. This may indicate different regulation and trafficking of bradykinin B 2 compared to the angiotensin AT 1 receptor.
The rate of decrease in surface binding of both B 2 wt and the chimera B 2 eGFP is strongly dependent on the expression levels. However, comparison of the constructs at two different expression levels clearly revealed that fusion of eGFP to the receptor C-terminus strongly reduced sequestration as an effect of long-term BK stimulation, blocking it completely at the high expression level (10 pmol/mg protein) and strongly slowing it down at the lower level (4 pmol/mg protein). As the internalization rates of B 2 wt and B 2 eGFP were comparable, this suggests the possibility that the B 2 eGFP chimera has either a higher recycling rate than B 2 wt, or that it continues to recycle, whereas B 2 wt is degraded on prolonged stimulation. The results of the recovery experiment ( Figure 5 ) point to the latter possibility, because even after 7 h of stimulation, most of the internalized B 2 eGFP low receptor could be restored to the cell surface, whereas this was not the case for B 2 wt low .
To identify the cause of the different behavior of B 2 wt and the chimera B 2 eGFP, several possibilities have to be taken into account. For example, our data demonstrate that the chimera B 2 eGFP can interact properly with kinases involved in receptor internalization, but owing to the many more spots observed for the chimera, even in the absence of BK (data not shown), we were not able to perform two-dimensional phosphopeptide mapping of the chimera, as successfully carried out for B 2 wt (Kalatskaya et al., 2004) . The strong basal phosphorylation observed in our experiment with B 2 eGFP may, therefore, result in part from phosphorylation of the eGFP-domain itself. Furthermore, it is conceivable that a specific phosphorylation pattern, generated during recycling of the receptor, is necessary to finally direct an internalized receptor to the degradation pathway and that this pattern cannot be created in the presence of eGFP fused to the C-terminus. Simaan et al. (2005) recently showed that proper interaction of the bradykinin B 2 receptor with barrestin2 is important for recycling and resensitization of the receptor after stimulation. Fusion of eGFP to the receptor C-terminus might affect this interaction in a manner that favors recycling over degradation. Of course, other processes such as ubiquitination, that are widely discussed for receptor internalization and downregulation (Haglund et al., 2003; Shenoy and Lefkowitz, 2005) , may be also involved and could be hamperedalthough not completely blocked -by the C-terminal presence of eGFP.
Taken together, our results demonstrate that internalization of B 2 wt is most likely required for its down-regulation. However, while fusion of eGFP to the C-terminus does not affect most of the features of the receptor, such as receptor affinity shift or ligand-induced receptor internalization, it does strongly reduce receptor down-regulation through promotion of the recycling of internalized receptors over degradation. Therefore, data obtained in recovery and localization experiments with eGFP-tagged GPCRs should be interpreted with caution as to whether the results also apply to the wild-type receptor. As the presence of eGFP at the C-terminus results in uncoupling of the processes of internalization and down-regulation, the use of eGFP-fusion proteins might represent an excellent tool to identify the determinants that are decisive for recycling vs. down-regulation of an internalized receptor through, e.g., overexpression of proteins that are supposed to be involved in receptor down-regulation. This information should eventually allow the generation of compounds that therapeutically enhance or reduce the action of endogenous hormones or exogenous drugs by influencing the balance between recycling and degradation of the GPCRs that mediate their effects.
Materials and methods

Expression vector and expression system
For expression of B 2 wt, we used the sequence starting with the third encoded methionine (Hess et al., 1992) . For generation of the B 2 eGFP chimera, the sequence for eGFP taken from the pEGFP-C1 vector (Clontech, Heidelberg, Germany) was joined to the C-terminus of B 2 wt using standard PCR technology with a chimeric primer that included the start codon of eGFP and left out the B 2 wt stop codon (Faussner et al., 2003) . For stable construct expression, the Flp-In system (Invitrogen, Karlsruhe, Germany) was employed, whereby the vector containing the gene of interest is inserted at a specific position into the genome of a commercially available host cell line (Flp-Inீ T-REx-293; Invitrogen) through the transient co-expression of a recombinase.
All receptor coding sequences were preceded at the N-terminus by a single hemagglutinin (HA)-tag (MGYPYDVPDYAGS), with the last two amino acids (GS) of the tag generated by the insertion of a BamHI site, and were cloned into the HindIII and the XhoI sites of the pcDNA5/FRT vector. HEK 293 cells were transfected using Fugene (Roche, Mannheim, Germany) according to the manufacturer's instructions and stable clones were selected using 250 mg/ml hygromycin B. The cells were cultivated in DMEM supplemented with 10% fetal calf serum and penicillin/ streptomycin. For monolayer experiments requiring rinsing of the cells, poly-D-lysine-treated w0.01% in phosphate-buffered saline (PBS)x multi-well plates were used.
Binding studies: determination of affinity (K d ) shift at 48C and at 378C
To compare the binding affinities of the constructs at 48C and at 378C, receptor sequestration was inhibited by pretreatment of cell monolayers in 48-well plates with 100 mM phenylarsine oxide (PAO) for 5 min at 378C, as recently reported . Thereafter, cells were rinsed with PBS and incubated with increasing concentrations of w 3 HxBK (0.01-30 nM) in incubation buffer (40 mM PIPES, 109 m NaCl, 5 mM KCl, 0.1% glucose, 0.05% BSA, 2 mM CaCl 2 , 1 mM MgCl 2 , pH 7.4, and the protease inhibitors 2 mM bacitracin, 0.8 mM 1,10-phenanthroline, and 100 mM captopril). After 30 min, the plates were placed on ice and washed with PBS either immediately (K d at 378C) or after an additional incubation step for 90 min on ice (K d at 48C). Surface-bound w 3 HxBK was dissociated in both cases using an icecold dissociation solution (0.2 M acetic acid/0.5 M NaCl, pH 2.7) for 10 min and samples were then transferred to scintillation vials. The radioactivity of all samples was then determined in a b-counter after addition of scintillation fluid. Non-specific binding was measured in the presence of 5 mM unlabeled BK and subtracted from total binding to obtain the specific values.
Internalization of w
HxBK
Cells seeded on 24-well plates were rinsed three times with PBS and incubated with w 3 HxBK (-1.5 nM) in incubation buffer for 90 min on ice to reach equilibrium binding. Thereafter, w 3 HxBK internalization was initiated by placing the plates in a water bath at 378C. At the times indicated, the internalization process was stopped by putting the plates back on ice and washing them with ice-cold PBS. Surface-bound w 
Receptor phosphorylation
Confluent cells on six-well plates were washed twice with phosphate-free DMEM, incubated for 3 h at 378C in the same medium, and labeled with 0.2 mCi/ml w 32 Px orthophosphate for 10-12 h. After exposure to 1 mM BK for 5 min at 378C, monolayers were solubilized in 0.5 ml of RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 2 mM EDTA, pH 7.5) supplemented with 0.5 mM Pefabloc SC (Roche) and 10 mM each of 1,10-phenanthroline, aprotinin, leupeptin, and pepstatin A and phosphatase inhibitors (25 mM NaF, 1 mM sodium orthovanadate, 0.3 mM okadaic acid)
for 1 h at 48C with gentle rocking. The lysate was centrifuged at 6000 g for 20 min at 48C. The supernatant was incubated with 15 ml of anti-HA affinity matrix (Roche) for 4 h at 48C. The mixture was then washed twice with RIPA buffer and once with distilled water. Electrophoresis on a 10% SDS polyacrylamide gel and electroblotting were carried out as previously described (Kalatskaya et al., 2004) . The proteins of interest were identified by autoradiography.
Determination of BK stability in culture medium
To determine the stability of BK in media with differently treated fetal calf serum (with and without incubation for 2 h in a water bath at 608C), BK was added to cell monolayers (48-well plates) in these media (500 ml) to a final concentration of 10 mM and incubated at 378C for the times indicated. Thereafter, 10 ml of the respective medium was added to 150 ml of 2 nM w 3 HxBK in incubation buffer and binding to cells expressing B 2 wt in 48-well plates was determined as described above at 48C. The reduction in w 3 HxBK binding was expressed as a percentage of the binding measured in B 2 wt control cells that received 10 ml of the media without addition of BK.
Receptor down-regulation and recovery
For down-regulation experiments, confluent cell monolayers in 48-well plates were incubated with 10 mM BK in 500 ml of medium containing 10% fetal calf serum that was pretreated for 2 h at 608C to reduce its proteolytic activity (inactivated serum). At the times indicated, both bound and free unlabeled BK were removed by treating the cell monolayers immediately with icecold dissociation solution for 10 min and rinsing them with PBS. Alternatively, for recovery experiments the cells were first washed with 1 ml of cell culture medium at 378C containing fresh (to promote degradation of residual BK) fetal calf serum, incubated in another 1 ml of medium for 1 h at 378C and then treated with the dissociation solution. To measure the remaining surface binding, all cells were incubated with approximately 2 nM w 3 HxBK in incubation buffer on ice. After 90 min, free w HxBK was determined after dissociation with ice-cold dissociation solution as described above. Non-specific binding was measured in the presence of 5 mM unlabeled BK.
Determination of total inositol phosphate (IP) release
Confluent monolayers in 12-well plates were incubated overnight with 0.5 ml of medium containing 10% inactivated fetal calf serum and 0.5 mCi w 3 Hxinositol. The cells were washed with PBS and preincubated on ice in incubation buffer supplemented with 50 mM LiCl with or without the addition of BK (10 -11 -10 -5 M). After 90 min the accumulation of IP was started by placing the cells in a water bath at 378C. The stimulation was terminated after 30 min by exchanging the buffer for 0.75 ml of ice-cold 20 mM formic acid solution. Total IPs were then determined using AG 1-X8 anion exchange columns as previously described (Kalatskaya et al., 2004) .
Protein determination
Total protein was quantified with the Micro BCA Protein assay reagent kit from Pierce (Rockford, IL, USA) using bovine serum albumin as standard.
Data analysis
All data analysis was performed using GraphPad Prism for Macintosh, Version 3.0a (GraphPad Software, Inc., San Diego, CA, USA).
